Titan Medical Inc.
TMDI · NASDAQ
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Revenue | $20 | $20 | $0 | $0 |
| % Growth | 0.5% | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $20 | $20 | -$0 | $0 |
| % Margin | 100% | 100% | – | – |
| R&D Expenses | $38 | $8 | $51 | $33 |
| G&A Expenses | $12 | $7 | $8 | $7 |
| SG&A Expenses | $12 | $8 | $8 | $7 |
| Sales & Mktg Exp. | $0 | $0 | -$0 | $0 |
| Other Operating Expenses | $1 | $0 | $0 | $0 |
| Operating Expenses | $51 | $16 | $59 | $40 |
| Operating Income | -$15 | -$23 | -$41 | -$23 |
| % Margin | -73% | -115.5% | – | – |
| Other Income/Exp. Net | $16 | -$1 | $11 | $0 |
| Pre-Tax Income | -$15 | -$24 | -$42 | -$23 |
| Tax Expense | $0 | $1 | $0 | $0 |
| Net Income | -$15 | -$25 | -$42 | -$23 |
| % Margin | -73.9% | -126.4% | – | – |
| EPS | -0.22 | -0.38 | -1.38 | -1.36 |
| % Growth | 42.1% | 72.5% | -1.5% | – |
| EPS Diluted | -0.22 | -0.38 | -1.38 | -1.36 |
| Weighted Avg Shares Out | 67 | 67 | 31 | 17 |
| Weighted Avg Shares Out Dil | 67 | 67 | 31 | 17 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $1 | $0 | $0 |
| Depreciation & Amortization | $1 | $0 | $0 | $0 |
| EBITDA | -$14 | -$23 | -$41 | -$23 |
| % Margin | -69.6% | -114.3% | – | – |